Use of molecular targeted agents for the diagnosis, staging and therapy of neuroendocrine malignancy.

Use of molecular targeted agents for the diagnosis, staging and therapy of neuroendocrine malignancy.

Item
http://www.wikidata.org/entity/Q34256413
Nuclear medicine imaging of gastro-entero-pancreatic neuroendocrine tumors. The key role of cellular differentiation and tumor grade: from theory to clinical practice.MALDI-MS-Based Profiling of Serum Proteome: Detection of Changes Related to Progression of Cancer and Response to Anticancer Treatment.Current role of metaiodobenzylguanidine in the diagnosis of pheochromocytoma and medullary thyroid cancer.Mimics of pancreatic ductal adenocarcinoma.Depicting medullary thyroid cancer recurrence: the past and the future of nuclear medicine imaging.Imaging in neuroendocrine tumors: an update for the clinician.PET imaging of tumours with a 64Cu labeled macrobicyclic cage amine ligand tethered to Tyr3-octreotate.Localization and prediction of malignant potential in recurrent pheochromocytoma/paraganglioma (PCC/PGL) using 18F-FDG PET/CT.Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized?Chemotherapy in NETs: When and how.Octreotide Does Not Inhibit Proliferation in Five Neuroendocrine Tumor Cell Lines.[Ductal adenocarcinoma and unusual differential diagnosis].International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New NomenclatureIs there still a role for SPECT–CT in oncology in the PET–CT era?ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues
P2860

Use of molecular targeted agents for the diagnosis, staging and therapy of neuroendocrine malignancy.

Item
http://www.wikidata.org/entity/Q34256413
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Use of molecular targeted agen ...... of neuroendocrine malignancy.
@ast
Use of molecular targeted agen ...... of neuroendocrine malignancy.
@en
Use of molecular targeted agen ...... of neuroendocrine malignancy.
@nl
type
label
Use of molecular targeted agen ...... of neuroendocrine malignancy.
@ast
Use of molecular targeted agen ...... of neuroendocrine malignancy.
@en
Use of molecular targeted agen ...... of neuroendocrine malignancy.
@nl
prefLabel
Use of molecular targeted agen ...... of neuroendocrine malignancy.
@ast
Use of molecular targeted agen ...... of neuroendocrine malignancy.
@en
Use of molecular targeted agen ...... of neuroendocrine malignancy.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Use of molecular targeted agen ...... of neuroendocrine malignancy.
@en
P2093
P2860
P304
P31
P356
10.1102/1470-7330.2010.9007
P478
P577
P5875
P698
P921
P932